PI3K GENE MUTATION
Clinical trials for PI3K GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new PI3K GENE MUTATION trials appear
Sign up with your email to follow new studies for PI3K GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare blood vessel disorders: targeted drugs enter trial
Disease control Recruiting nowThis phase 2 trial is testing two targeted drugs—alpelisib and mirdametinib—in people with vascular malformations (abnormal blood vessels). The study enrolls 50 participants aged 2 and older, split into two groups based on whether their malformations are slow-flow or fast-flow. E…
Matched conditions: PI3K GENE MUTATION
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
New precision drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage study tests a new drug, OKI-219, designed to attack cancer cells with a specific mutation (PI3KαH1047R). About 200 adults with advanced solid tumors or breast cancer will receive the drug alone or with other treatments. The goal is to find safe doses and see if t…
Matched conditions: PI3K GENE MUTATION
Phase: PHASE1 • Sponsor: OnKure, Inc. • Aim: Disease control
Last updated Jun 08, 2026 13:05 UTC